Your business has many vital parts, and each one is crucial for smooth operations. You prioritize employee productivity and operational efficiency, but what about your supply chain? Your supply chain ...

Once considered a back-office function, the supply chain has emerged as a central driver of growth, resilience, and innovation. Yet only 29% of supply chain organizations are considered “future ready, ...

Global supply chains can be incredibly powerful in what they accomplish, but they are also extremely vulnerable. Over the past few years, we’ve seen how disruption in one region of the world can cause ...

Five tactical insights for defense acquisition professionals navigating the most challenging supply chain environment in history. In arguably one of the most unpredictable geopolitical climates in ...

All businesses seek to avoid risks that inevitably come their way. Building resilient and sustainable supply chains is emerging as an important element in corporate risk-mitigation strategies. Getting ...

Supply chain disruption and persistent inflation remain critical issues in the global economy, with ongoing geopolitical tensions, the evolution of digital threats, and increasing emphasis on ...

Supply chain leaders and managers in the medical device industry are often puzzled by the multitude of strategies, corporate directives, and transformation programs that claim to improve the ...

The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience. BY Eric Schrader In a world ...

Supply chains have typically been quiet enablers, optimized for cost, consistency, and scale. But in today’s volatile world, supply chains must no longer be designed solely for efficiency; they must ...

In the global supply chain, change is table stakes. However, the pace and scope of this decade’s disruptions — from the pandemic to geopolitical conflicts and climate disasters — are unlike anything ...

Trade unpredictability exposes vulnerabilities in the pharmaceutical supply chain that must be addressed to build resilient systems ensuring patient access despite geopolitical challenges.